SMN Deficiency Destabilizes ABCA1 Expression in Human Fibroblasts: Novel Insights in Pathophysiology of Spinal Muscular Atrophy

Int J Mol Sci. 2023 Feb 2;24(3):2916. doi: 10.3390/ijms24032916.

Abstract

The deficiency of survival motor neuron protein (SMN) causes spinal muscular atrophy (SMA), a rare neuromuscular disease that affects different organs. SMN is a key player in RNA metabolism regulation. An intriguing aspect of SMN function is its relationship with plasma membrane-associated proteins. Here, we provide a first demonstration that SMN affects the ATP-binding cassette transporter A1, (ABCA1), a membrane protein critically involved in cholesterol homeostasis. In human fibroblasts, we showed that SMN associates to ABCA1 mRNA, and impacts its subcellular distribution. Consistent with the central role of ABCA1 in the efflux of free cholesterol from cells, we observed a cholesterol accumulation in SMN-depleted human fibroblasts. These results were also confirmed in SMA type I patient-derived fibroblasts. These findings not only validate the intimate connection between SMN and plasma membrane-associated proteins, but also highlight a contribution of dysregulated cholesterol efflux in SMA pathophysiology.

Keywords: ABCA1; SMA; SMN; cholesterol; plasma membrane.

MeSH terms

  • ATP Binding Cassette Transporter 1 / genetics
  • ATP Binding Cassette Transporter 1 / metabolism
  • Fibroblasts / metabolism
  • Humans
  • Membrane Proteins / metabolism
  • Motor Neurons* / metabolism
  • Muscular Atrophy, Spinal* / metabolism
  • Survival of Motor Neuron 1 Protein / genetics
  • Survival of Motor Neuron 1 Protein / metabolism
  • Transcription Factors / metabolism

Substances

  • Transcription Factors
  • Membrane Proteins
  • Survival of Motor Neuron 1 Protein
  • ABCA1 protein, human
  • ATP Binding Cassette Transporter 1

Grants and funding

This research received no external funding.